Freecash introduces a zero-investment way to earn money by watching movies 
Taxinexo Advances Large-Scale Commercial Deployment of Level 4 Autonomous Vehicles Across the United States 
TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering 
Authority Engine Launches AI Ads Engine, Delivering 37% Click-Through Rates and $0.06 Cost Per Action Through Autonomous Campaign Optimization Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in…
Sigilon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
BioRestorative Therapies Announces Filing of 2019 Annual Report on Form 10-K
MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”)…
vTv Therapeutics Announces Initiation of Study Evaluating TTP399’s Potential to Reduce Risk of Diabetic Ketoacidosis in Patients with Type 1 Diabetes
HIGH POINT, N.C., March 18, 2021 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage…
Trillium Therapeutics Reports Annual Operating and Financial Results and Sets Date for R&D Day
Wide-ranging transformation program completed R&D Day scheduled for April 28, 2021, to provide data updates,…
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021
-AGTC will highlight the value of the patient voice in gene therapy development- GAINESVILLE, Fla….
Santhera’s Shareholders Approve all Board Proposals at Today’s Extraordinary General Meeting
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN…
Segra International Announces Development and Validation of In-House Assay for Hop Latent Viroid (HLVd)
VANCOUVER, British Columbia, March 18, 2021 (GLOBE NEWSWIRE) — Segra International Corp, a leading cannabis…
Skye Bioscience to Present at Benzinga Biotech Small Cap Conference
San Diego, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE”…
Sorrento Announces First Patient Treated in Phase IB AL Amyloidosis Trial with STI-6129, an Anti-CD38 Antibody-Drug Conjugate
STI-6129 is an antibody-drug conjugate (ADC) composed of a fully human monoclonal anti-CD38 antibody covalently…
Arcutis Announces First Patient Enrolled in Phase 2a Clinical Trial Evaluating ARQ-252 as a Potential Treatment for Vitiligo
ARQ-252 is a potent and highly selective topical JAK1 inhibitor offering potential safety advantages over…
Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference
– Demonstrated Whole-Body MRI captures heterogeneity and provides key disease severity and progression information correlated with…
Dyadic Advancing Towards Human Clinical Trial of its SARS-CoV-2-S-RBD vaccine candidate, DYAI-100
Israel Institute for Biological Research (IIBR) reports successful challenge studies using human ACE2 transgenic mice…
Yield10 Bioscience to Present at the Benzinga Biotech Small Cap Conference on March 25, 2021
WOBURN, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural…
Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference
CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology…
ORYZON to Participate in Upcoming Virtual International Conferences in March and April
BIO-Europe Spring 2021 Kempen Life Sciences Conference 4th SACHS Annual Neuroscience Innovation Forum 2021 MADRID,…
Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Company to host an investor conference call and webcast at 4:30pm ET on that day…
APIE Therapeutics Prepares to Advance Pipeline Programs with Appointment of Robert Willette, Ph.D. as Chief Scientific Officer
Cary, NC, March 18, 2021 (GLOBE NEWSWIRE) — APIE Therapeutics, a preclinical biopharma company pioneering…
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world setting
Helsinn publishes PROVe MF-CTCL study providing new data for mechlorethamine gel use in a real-world…